Pulsed Energy Therapy for Biological Tissues via Heat Shock Protein Activation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for chronic progressive diseases (CPDs) are limited in effectiveness and often come with significant side effects due to their inability to address the underlying causes, requiring long-term use of anti-inflammatory and immunosuppressive drugs, radiation therapy, or stem cell transplantation, which are costly and have adverse effects.

Innovation Solution

A process involving a pulsed energy source that raises the temperature of biological tissues or fluids to stimulate heat shock proteins for protein repair without damaging the tissue, using parameters such as wavelength, frequency, duty cycle, and pulse train duration to achieve a therapeutic effect while maintaining average temperature within safe limits.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If anti-inflammatory and immunosuppressive drugs are used long-term to treat CPDs, then disease progression is slowed, but side effects and complications increase

Engineering Contradiction:
Improvedisease progression controlVSAvoidside effects and complications
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies controlled thermal stress (heat shock) to stimulate the body's own protective mechanisms. The harmful effect of heat is converted into a beneficial therapeutic response by inducing heat shock proteins that protect cells from damage and promote repair, thereby treating CPDs through the body's natural protective responses rather than suppressing the immune system with conventional drugs.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The treatment enables the body to heal itself by stimulating endogenous heat shock protein production. Instead of relying on external pharmaceutical interventions, the thermal therapy triggers the body's own protective mechanisms to address cellular damage and disease progression, reducing dependence on long-term medication and its associated side effects.

Inventive Principle:
Principle #25Self-service

2Reliability

If radiation therapy is used to treat CPDs, then disease progression is inhibited, but long-term survival is compromised due to severe side effects

Engineering Contradiction:
Improvedisease progression inhibitionVSAvoidlong-term survival
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The patent changes the physical parameters of energy delivery by using controlled, low-level thermal stress instead of high-energy radiation. By adjusting temperature parameters to induce heat shock protein activation without causing tissue damage, the treatment achieves disease inhibition while preserving long-term survival, avoiding the severe side effects associated with radiation therapy.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If stem cell transplantation is performed to treat CPDs, then tissue regeneration is achieved, but cost and procedural complexity increase

Engineering Contradiction:
Improvetissue regenerationVSAvoidprocedural complexity and cost
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The thermal therapy stimulates the body's own stem cells and repair mechanisms to regenerate damaged tissue. By inducing heat shock protein activation, the treatment promotes endogenous tissue regeneration without requiring external stem cell transplantation, thereby reducing procedural complexity and cost while achieving similar or superior regenerative outcomes.

Inventive Principle:
Principle #25Self-service

4Reliability

If targeted drug therapy is used to address specific cellular proteins in CPDs, then disease-specific treatment is achieved, but the complexity of identifying and targeting proteins increases difficulty

Engineering Contradiction:
Improvedisease-specific treatment effectivenessVSAvoidprotein identification and targeting complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent employs a universal treatment mechanism that works across multiple types of CPDs with different underlying causes. By inducing heat shock protein activation through thermal stress, the treatment addresses common cellular stress responses shared by various diseases, eliminating the need for complex protein-specific targeting and enabling a single therapeutic approach to treat diverse conditions.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach effectively stimulates heat shock protein activation to facilitate protein repair, potentially breaking the vicious cycle of CPDs, offering a physiologically safe and effective treatment that can be applied prophylactically or therapeutically, reducing disease progression and side effects.

Implementation Method 1

A process involving a pulsed energy source that raises the temperature of biological tissues or fluids to stimulate heat shock proteins for protein repair

Methodology Applied
Scientific EffectThermal heating: Heating

Data Source

PatentUS10953241B2Process for providing protective therapy for biological tissues or fluids
Publication Date: 2021.03.23 OJAI RETINAL TECHNOLOGY LLC
  • US10953241B2 patent drawing
  • US10953241B2 patent drawing
  • US10953241B2 patent drawing

AI summary

A process that provides protective therapy for biological tissues or fluids includes applying a pulsed energy source to a target tissue or a target fluid having a chronic progressive disease or a risk of having a chronic progressive disease to therapeutically or prophylactically treat the target tissue or target fluid. The pulsed energy source has energy parameters selected so as to raise the target tissue or bodily target fluid temperature up to a predetermined temperature for a short period of time to achieve a therapeutic or prophylactic effect, while the average temperature rise of the target tissue or target fluid over a longer period of time is maintained at or below a predetermined level so as not to permanently damage the target tissue or target fluid.